Autoregulation of the immune response in autoimmune disease and cardiac transplantation by photoinactivated autologous lymphocytes.
These studies demonstrate that photochemotherapy can be successfully evaluated in animal models. The therapy mediates specific suppression of immune responses and appears to operate at the level of the effector T cells. Future studies will focus on isolation and characterization of the host response to photochemotherapy. The extention of this form of therapy to conditions mediated by dysfunctional regulation of effector T cells is already in progress in clinical trials of cardiac allograft transplantation and autoimmune disease. The results of these trials will provide more evidence on the role of this form of therapy in autoregulation of the immune response.
Berger
C L
CL
Department of Dermatology, Columbia University, New York, New York 10032.
Edelson
R L
RL
Edwards
N
N
Sanchez
J
J
Coppey
L
L
He
X
X
Marboe
C
C
Rose
E
E
D000818:Animals; D001327:Autoimmune Diseases / Q000276:immunology*; D016027:Heart Transplantation; D006706:Homeostasis; D007937:Leukapheresis; D008180:Lupus Erythematosus, Systemic / Q000276:immunology; D007959:Lymphocyte Culture Test, Mixed; D008252:Macaca fascicularis; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D011701:PUVA Therapy; D010215:Papio; D013601:T-Lymphocytes / Q000276:immunology*